MedPath

Competative study of letrozole and clomiphene citrate verses letrozole alone in ovarian stimulatio

Not Applicable
Completed
Registration Number
CTRI/2023/03/050914
Lead Sponsor
o sponser is required
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
180
Inclusion Criteria

Female with anovulatory cycle

Exclusion Criteria

1.Woman not giving consent

2.current hormonal contraception use

3.other known cause of infertility (tubal factor)

4.uncorrected thyroid disease

5.untreated hyperprolactinemia

6.medical conditions not well controlled or not recommended during pregnancy ( uncontrolled type 1 and type 2 diabetes mellitus, hypertension, endometrial hyperplasia/cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath